Koteng Bio Completes Enrollment in Clinical Trial for Scalp Filler; East China Medicine Reports RMB 1.65 Million in Sales

Dec 14, 2023 17:00 CST Updated 17:00

Techderm

Medical Biomaterials R&D Developer

Industry Trends

丨Techderm "Scalp Filler" Successfully Completes Clinical Trial Enrollment

Recently, HangZhou Techderm Biological Products CO., Ltd successfully completed the enrollment of all subjects in a prospective, multi-center, randomized, untreated control, evaluator-blinded, superiority clinical trial for the efficacy and safety of "scalp filler" used to fill the dermal layer of the scalp for treating non-scarring alopecia.

According to publicly available information, the aforementioned product is composed of phosphate-buffered saline, non-crosslinked hyaluronic acid, and other components. The product is used for filling the dermal layer of the scalp to treat non-scarring alopecia, playing a role in protecting hair follicles and promoting growth, without entering the systemic circulation.

丨Huadong Medicine: Sell amount of 1.6485 million yuan, accounting for 1.52% of the day's outflow.

On December 13, Huadong Medicine received a margin purchase of 11.1966 million yuan, accounting for 11.41% of the day's purchase amount. The current margin balance is 1.019 billion yuan, accounting for 1.46% of the market value, surpassing the historical 70th percentile level.

Date	Financing Changes	Financing Balance
December 13	215,400	1.019 billion
December 12	3.2388 million	1.018 billion
December 11	-3.678 million	1.015 billion
December 8	-20,970,500	1.019 billion
December 7	-202.11 million	1.04 billion

Industry Regulation

丨A Medical Aesthetic Clinic in Shenzhen Fined 2,866 Yuan

A medical aesthetics clinic in Shenzhen was warned and fined 2,866 yuan by the Nanshan Branch of the Shenzhen Market Supervision Administration for illegal advertising practices. According to the announcement, the medical aesthetics clinic violated the Medical Advertising Management Regulations (2006 Revision), the Administrative Punishments Law of the People's Republic of China, and the Advertising Law of the People's Republic of China (2021 Revision), constituting an illegal advertising practice. The Nanshan Branch of the Shenzhen Market Supervision Administration issued a warning and imposed a fine of 2,866 yuan.

丨A Medical Institution in Xiamen Fined for Using Expired Medical Devices

Recently, the Comprehensive Law Enforcement Team of Xiamen Market Supervision Administration conducted a special inspection on the use of pharmaceuticals and medical devices in medical institutions, and imposed administrative penalties on a medical institution for using expired medical devices.

Law enforcement officers found expired medical devices such as " disposable sterile syringes," "absorbable surgical sutures," and " disposable heparin caps" in the injection room and operating room of the party's business premises. The party’s use of expired medical devices violated relevant provisions of the Regulations on the Supervision and Administration of Medical Devices. Law enforcement officers ordered the party to rectify the situation, imposed a fine of 20,000 yuan, and confiscated the involved expired medical devices.